Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 12 Jul 2023

Similar additive effects of doxorubicin in combination with photon or proton irradiation in soft tissue sarcoma models

in Molecular and Cellular Oncology

Teresa Bernardo
Carina Behrends
Diana Klein
Anna Kuntze
Beate Timmermann
Cläre von Neubeck

Frontiers in Oncology

doi 10.3389/fonc.2023.1211984

3,778 views
3 citations

Review

Published on 12 Jul 2023

Photodynamic therapy induced cell cycle arrest and cancer cell synchronization: review

in Molecular and Cellular Oncology

Kave Moloudi
Heidi Abrahamse
Blassan P. George

Frontiers in Oncology

doi 10.3389/fonc.2023.1225694

8,762 views
34 citations

Editorial

Published on 12 Jul 2023

Editorial: Overcoming the cell membrane to target intracellular oncoproteins

in Molecular and Cellular Oncology

Christopher J. Brown
Yong Li
Kanaga Sabapathy

Frontiers in Oncology

doi 10.3389/fonc.2023.1222095

1,684 views

Editorial

Published on 07 Jul 2023

Editorial: Strategies to overcome tumor evasion and resistance to immunotherapies by targeting immune suppressor cells

in Molecular and Cellular Oncology

Yu Saida
Satoshi Watanabe
Shohei Koyama
Yosuke Togashi
Toshiaki Kikuchi

Frontiers in Oncology

doi 10.3389/fonc.2023.1240926

2,724 views
3 citations

Review

Published on 07 Jul 2023

Characteristics and molecular mechanism of drug-tolerant cells in cancer: a review

in Molecular and Cellular Oncology

Xian-Wen Liang
Bing- Liu
Jia-Cheng Chen
Zhi Cao
Feng-ran Chu
Xiong Lin
Sheng-Zhong Wang
Jin-Cai Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1177466

6,223 views
18 citations

Brief Research Report

Published on 06 Jul 2023

Gain of chromosome 21 increases the propensity for P2RY8::CRLF2 acute lymphoblastic leukemia via increased HMGN1 expression

in Molecular and Cellular Oncology

Elyse C. Page
Susan L. Heatley
Jacqueline Rehn
Paul Q. Thomas
David T. Yeung
Deborah L. White

Frontiers in Oncology

doi 10.3389/fonc.2023.1177871

5,125 views
8 citations

Review

Published on 04 Jul 2023

Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target

in Molecular and Cellular Oncology

Nataliya Pidkovka
Abbes Belkhiri

Frontiers in Oncology

doi 10.3389/fonc.2023.1079041

4,510 views
9 citations

Original Research

Published on 04 Jul 2023

Copine 7 promotes colorectal cancer proliferation through PKM2 interaction and MAPK signaling pathway

in Molecular and Cellular Oncology

Tianwen Yu
Changhao Huang
Chen Lai
Qing He
Weijie Yuan
Zihua Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1166444

3,961 views
7 citations

Editorial

Published on 04 Jul 2023

Editorial: Extracellular vesicles in gastrointestinal cancers

in Molecular and Cellular Oncology

Liang Li
Yan Ling
Zhangjun Cheng
Norbert Hüser
William C. Cho

Frontiers in Oncology

doi 10.3389/fonc.2023.1240002

1,975 views

Mini Review

Published on 04 Jul 2023

Three-dimensional heterotypic colorectal cancer spheroid models for evaluation of drug response

in Molecular and Cellular Oncology

Jia Ning Nicolette Yau
Giulia Adriani

Frontiers in Oncology

doi 10.3389/fonc.2023.1148930

12,287 views
18 citations

General Commentary

Published on 03 Jul 2023

Commentary: Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer

in Molecular and Cellular Oncology

Yi-Heng Du

Frontiers in Oncology

doi 10.3389/fonc.2023.1159828

2,215 views

Original Research

Published on 03 Jul 2023

F-ATP synthase inhibitory factor 1 regulates metabolic reprogramming involving its interaction with c-Myc and PGC1α

in Molecular and Cellular Oncology

Lishu Guo
Zhenglong Gu

Frontiers in Oncology

doi 10.3389/fonc.2023.1207603

4,384 views
5 citations

Review

Published on 29 Jun 2023

Tumor-derived extracellular vesicle nucleic acids as promising diagnostic biomarkers for prostate cancer

in Molecular and Cellular Oncology

Yanjun Diao
Bingbing Zhu
Ting Ding
Rui Li
Jinjie Li
Liu Yang
Lei Zhou
Xiaoke Hao
Jiayun Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1201554

3,360 views
7 citations

Mini Review

Published on 29 Jun 2023

Defining the elusive oncogenic role of the methyltransferase TMT1B

in Molecular and Cellular Oncology

Sarah E. Denford
Brian T. Wilhelm

Frontiers in Oncology

doi 10.3389/fonc.2023.1211540

4,435 views
6 citations

Brief Research Report

Published on 29 Jun 2023

Biglycan and reduced glycolysis are associated with breast cancer cell dormancy in the brain

in Molecular and Cellular Oncology

Ashley Sunderland
Jennifer Williams
Tereza Andreou
Nora Rippaus
Christopher Fife
Fiona James
Yolanda Dyah Kartika
Valerie Speirs
Ian Carr
Alastair Droop

Frontiers in Oncology

doi 10.3389/fonc.2023.1191980

5,855 views
18 citations

Editorial

Published on 27 Jun 2023

Editorial: Insights into non-coding RNAs in programmed cell death, from molecular mechanism of tumorigenesis to therapeutic targets

in Molecular and Cellular Oncology

Jinhui Liu
Peixin Dong

Frontiers in Oncology

doi 10.3389/fonc.2023.1239782

1,701 views

Editorial

Published on 26 Jun 2023

Editorial: The role of Helicobacter pylori in gastric carcinogenesis

in Molecular and Cellular Oncology

Javier Torres
Rui M. Ferreira
Ikuko Kato

Frontiers in Oncology

doi 10.3389/fonc.2023.1233890

2,305 views
1 citation

Review

Published on 23 Jun 2023

Copper in cancer: from limiting nutrient to therapeutic target

in Molecular and Cellular Oncology

Xiaolong Tang
Zaihua Yan
Yandong Miao
Wuhua Ha
Zheng Li
Lixia Yang
Denghai Mi

Frontiers in Oncology

doi 10.3389/fonc.2023.1209156

30,742 views
88 citations

Review

Published on 22 Jun 2023

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy

in Molecular and Cellular Oncology

Paulina Czajka-Francuz
Maria J. Prendes
Arun Mankan
Ángela Quintana
Sarabjot Pabla
Shakti Ramkissoon
Taylor J. Jensen
Sandra Peiró
Eric A. Severson
Bhagelu R. Achyut

Frontiers in Oncology

doi 10.3389/fonc.2023.1200646

13,430 views
55 citations

Review

Published on 22 Jun 2023

Targeting cyclin D1 as a therapeutic approach for papillary thyroid carcinoma

in Molecular and Cellular Oncology

Wei Cai
Lin-Zhen Shu
Ding-Jie Liu
Lv Zhou
Meng-Meng Wang
Huan Deng

Frontiers in Oncology

doi 10.3389/fonc.2023.1145082

4,787 views
13 citations

Original Research

Published on 20 Jun 2023

The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment

in Molecular and Cellular Oncology

Daniela Barone
Carmelina Antonella Iannuzzi
Iris Maria Forte
Maria Carmen Ragosta
Maria Cuomo
Milena Dell’Aquila
Angela Altieri
Antonella Caporaso
Rosa Camerlingo
Maria Manuela Rigano

Frontiers in Oncology

doi 10.3389/fonc.2023.1117262

3,355 views
2 citations

Review

Published on 19 Jun 2023

Metabolo-epigenetic interplay provides targeted nutritional interventions in chronic diseases and ageing

in Molecular and Cellular Oncology

Marta Gómez de Cedrón
Rocío Moreno Palomares
Ana Ramírez de Molina

Frontiers in Oncology

doi 10.3389/fonc.2023.1169168

8,191 views
15 citations

Editorial

Published on 19 Jun 2023

Editorial: Vascular co-option and beyond for cancer biology

in Molecular and Cellular Oncology

Francesco Pezzella
Chao-Nan Qian

Frontiers in Oncology

doi 10.3389/fonc.2023.1227540

1,845 views
4 citations

Review

Published on 16 Jun 2023

Emerging diversity in extracellular vesicles and their roles in cancer

in Molecular and Cellular Oncology

Ikjot S. Sohal
Andrea L. Kasinski

Frontiers in Oncology

doi 10.3389/fonc.2023.1167717

10,758 views
37 citations

3,144 articles

articles

Similar additive effects of doxorubicin in combination with photon or proton irradiation in soft tissue sarcoma models

Photodynamic therapy induced cell cycle arrest and cancer cell synchronization: review

Editorial: Overcoming the cell membrane to target intracellular oncoproteins

Editorial: Strategies to overcome tumor evasion and resistance to immunotherapies by targeting immune suppressor cells

Characteristics and molecular mechanism of drug-tolerant cells in cancer: a review

Gain of chromosome 21 increases the propensity for P2RY8::CRLF2 acute lymphoblastic leukemia via increased HMGN1 expression

Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target

Copine 7 promotes colorectal cancer proliferation through PKM2 interaction and MAPK signaling pathway

Editorial: Extracellular vesicles in gastrointestinal cancers

Three-dimensional heterotypic colorectal cancer spheroid models for evaluation of drug response

Commentary: Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer

F-ATP synthase inhibitory factor 1 regulates metabolic reprogramming involving its interaction with c-Myc and PGC1α

Tumor-derived extracellular vesicle nucleic acids as promising diagnostic biomarkers for prostate cancer

Defining the elusive oncogenic role of the methyltransferase TMT1B

Biglycan and reduced glycolysis are associated with breast cancer cell dormancy in the brain

Editorial: Insights into non-coding RNAs in programmed cell death, from molecular mechanism of tumorigenesis to therapeutic targets

Editorial: The role of Helicobacter pylori in gastric carcinogenesis

Copper in cancer: from limiting nutrient to therapeutic target

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy

Targeting cyclin D1 as a therapeutic approach for papillary thyroid carcinoma

The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment

Metabolo-epigenetic interplay provides targeted nutritional interventions in chronic diseases and ageing

Editorial: Vascular co-option and beyond for cancer biology

Emerging diversity in extracellular vesicles and their roles in cancer